Trajectories of Physical Function in Canadian Children With Juvenile Idiopathic Arthritis

Clare Cunningham1,2, Meghan McPherson3,4, Lillian Lim5,6

  • 1British Columbia Children's Hospital, Vancouver, British Columbia, Canada.

PubMed

Insights

Most children with juvenile idiopathic arthritis (JIA) experience functional improvements within two years, but a significant portion, about one-third, show mild persistent impairments. Early assessment of physical function is key for identifying these long-term challenges.

Area of Science:

  • Pediatric Rheumatology
  • Clinical Research
  • Child Health Outcomes

Background:

  • Juvenile idiopathic arthritis (JIA) is a chronic condition affecting children, leading to potential long-term functional limitations.
  • Understanding the natural course of physical function in JIA is crucial for effective management and intervention.

Purpose of the Study:

  • To describe physical function trajectories in children newly diagnosed with JIA.
  • To identify specific trajectories associated with persistent functional impairments and their baseline predictors.

Main Methods:

  • Latent class trajectory analysis (LCTA) was used to identify distinct patterns of physical function over time.
  • Data from the Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) Registry (2017-2024) including Kids Disability Screen (KDS) scores were analyzed.
  • Classification trees were employed to predict trajectories with persisting impairments.

Main Results:

  • Five distinct physical function trajectories were identified in 940 children with JIA.
  • The majority of patients showed improving functional scores within the first year.
  • 38% of patients followed trajectories with mild persisting functional impairments, while 38% had impairments resolving within 1-2 years.

Conclusions:

  • Most children with JIA experience functional recovery within 1-2 years post-diagnosis.
  • A substantial minority (38%) exhibit mild persistent functional impairments, highlighting the need for ongoing monitoring.
  • Baseline Kids Disability Screen scores may help predict long-term functional outcomes.
Abstract

Related Concept Videos

Development of the Limb Synovial Joints01:07

Development of the Limb Synovial Joints

Joints form during embryonic development in conjunction with the formation and growth of the associated bones. The embryonic tissue that gives rise to all bones, cartilage, and connective tissues of the body is called mesenchyme.
The mesenchymal stem cells differentiate into chondrocytes that form the hyaline cartilage, and later the cartilaginous model of the bone. This model further transforms into a bone. This process is known as endochondral ossification.
During development, the limbs...
2.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
407
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.1K